You just read:

Akcea Initiates Phase 2 Study of AKCEA-APO(a)-L Rx in Patients with High Lp(a) and Cardiovascular Disease

News provided by

Ionis Pharmaceuticals, Inc.

Mar 30, 2017, 07:00 ET